Use of organs from donors testing positive for hepatitis B virus (HBV) may safely expand the
donor pool. The American Society of Transplantation convened a multidisciplinary expert …

Treatment of chronic hepatitis C virus (HCV) and hepatitis B virus (HBV) infection poses
unique challenges in patients with kidney disease. Direct-acting antivirals have been a …

Hepatitis B virus (HBV) poses a significant challenge for both dialysis patients and kidney
transplant recipients despite its decreasing rates, especially in developed countries. The …

The outcomes of kidney transplantation (KT) from hepatitis B surface antigen–positive
[HBsAg (+)] donors to HBsAg (−) recipients remain inconclusive, possibly due to substantial …

Objectives: The aim of this study was to assess the 1-year safety and effectiveness of HBV
Nucleic Acid Test positive (HBV NAT+) allografts in seronegative kidney transplant (KT) and …

Background Kidney transplantation is the therapy of choice for a patient with end-stage renal
disease. Although the number of patients with end-stage renal disease is in constant …

Transplantation of organs from hepatitis B virus (HBV)–exposed donors dates back to the
1980s. 1 The significant morbidity and mortality of people with end-stage renal, liver, heart …

Background Despite the importance of hepatitis B virus (HBV) immunization in kidney
transplantation (KT), data are lacking on fluctuations in hepatitis B surface antibody (anti …

Background Accepting kidneys for transplant from donors with a history of hepatitis B virus
infection may increase the availability of organs for those with end-stage kidney disease. In …

Background The demand for transplantable kidneys continues to outstrip supply, and the
risk of donor‐derived infection limits utilization. The effect of donor or recipient HBV status …